Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report

Ann Hematol. 2023 Nov;102(11):3271-3273. doi: 10.1007/s00277-023-05370-8. Epub 2023 Jul 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alemtuzumab / adverse effects
  • Antineoplastic Agents, Immunological* / therapeutic use
  • Hemophilia A* / chemically induced
  • Hemophilia A* / complications
  • Humans
  • Multiple Sclerosis* / diagnostic imaging
  • Multiple Sclerosis* / drug therapy

Substances

  • Alemtuzumab
  • Antineoplastic Agents, Immunological

Supplementary concepts

  • Factor 8 deficiency, acquired